News archives


OCTOBER - DECEMBER 17

JULY - SEPTEMBER 17

APRIL - JUNE 17

JANUARY - MARCH 17

OCTOBER - DECEMBER 16

JULY - SEPTEMBER 16

APRIL - JUNE 16

JANUARY - MARCH 16

OCTOBER - DECEMBER 15

JULY - SEPTEMBER 15

APRIL - JUNE 15

JANUARY - MARCH 15

OCTOBER - DECEMBER 14

JULY - SEPTEMBER 14

APRIL - JUNE 14

JANUARY - MARCH 14

OCTOBER - DECEMBER 13

JULY - SEPTEMBER 13

APRIL - JUNE 13

JANUARY - MARCH 13

OCTOBER - DECEMBER 12

JULY - SEPTEMBER 12

APRIL - JUNE 12

JANUARY - MARCH 12

OCTOBER - DECEMBER 11

JULY - SEPTEMBER 11

APRIL - JUNE 11

JANUARY - MARCH 11

OCTOBER - DECEMBER 10

JULY - SEPTEMBER 10

APRIL - JUNE 10

JANUARY - MARCH 10

OCTOBER - DECEMBER 09

JULY - SEPTEMBER 09

APRIL - JUNE 09

JANUARY - MARCH 09

OCTOBER - DECEMBER 08

JULY - SEPTEMBER 08

APRIL - JUNE 08

JANUARY - MARCH 08

OCTOBER - DECEMBER 07

JULY - SEPTEMBER 07

APRIL - JUNE 07

JANUARY - MARCH 07

 
  current news   Press   selected story    
     
  23 March 2016  
 
MRTF/SRF dependent transcriptional regulation of TAZ in breast cancer cells
 
 




Authors
Chen-Ying Liu1,2, Siew Wee Chan1, Fusheng Guo1, Aleksandra Toloczko1, Long Cui2,3, Wanjin Hong1,3

1  Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), 61,      Biopolis Drive, Proteos, Singapore 138673, Singapore;
2  Department of Colorectal and Anal Surgery, Xinhua Hospital, Shanghai Jiaotong University School of    Medicine, Shanghai 200092, China
3  Correspondence: Wanjin Hong, email: mcbhwj@imcb.a-star.edu.sg;
   Long Cui, email: longcuidr@126.com

Published in Oncotarget on 11 February 2016. (doi: 10.18632/oncotarget.7333.)

Abstract
Dysregulation of Hippo pathway results in activation of transcriptional co-activators YAP/TAZ, leading to tumorigenesis and tumor progression, which occurs in multiple cancers including breast cancer. Previously, we showed that upregulation of TAZ in breast cancer which plays a vital role in cell migration, invasion and tumorigenesis. Here, we show that upregulation of TAZ in breast cancers could also be due to the dysregulation of TAZ transcription. Heregulin b1 (HRG1) promotes TAZ mRNA expression level in breast cancer cells. TAZ is a direct target of MRTF/SRF transcriptional factors which are activated by HRG1 in breast cancer cells. Both MRTF/SRF and TAZ are the important downstream effectors mediating the biological function of HRG1. The mRNA expression level of TAZ is correlated with nuclear localization of MRTF in breast cancer cells and the expression level of MRTF/SRF direct target genes in breast cancers, which indicate the association between MRTF/SRF activity and TAZ expression in breast cancers. Our results provide new insights into the transcriptional regulation of TAZ and dysregulation mechanism of TAZ in breast cancers, which could be a new therapeutic strategy for breast cancer treatment.

Figure:

Figure legend: Correlation between TAZ and MRTF/SRF pathway in the TCGA breast cancer database. (A) TAZ expression level is correlated with the expression level of MRTF/SRF target genes in breast cancer. Co-expression data between TAZ and FLNA, SRF, MYH9, and VCL, respectively, in the breast cancer TCGA RNA-seq data were extracted from the cbioportal database. The value of Pearson's correlation coefficient and Spearman’s correlation coefficient were generated by the cbioportal database to measure the correlation of gene co-expression. (B) The expression levels of TAZ and MRTF/SRF target genes in the TCGA datasets from UCSC Cancer genomics browser were shown.

For more information on Wanjin HONG's lab, please click here.